Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$145.54 - $178.83 $291,225 - $357,838
2,001 Added 64.34%
5,111 $886 Million
Q1 2024

May 09, 2024

BUY
$165.67 - $199.94 $515,233 - $621,813
3,110 New
3,110 $526 Million
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $818,150 - $943,609
4,895 New
4,895 $852 Million
Q1 2023

May 12, 2023

BUY
$145.48 - $175.02 $111,583 - $134,240
767 Added 12.64%
6,836 $1.14 Billion
Q4 2022

Feb 14, 2023

BUY
$131.14 - $157.47 $795,888 - $955,685
6,069 New
6,069 $889 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Inceptionr LLC Portfolio

Follow Inceptionr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inceptionr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inceptionr LLC with notifications on news.